Comparison of low-density lipoprotein size by polyacrylamide tube gel electrophoresis and polyacrylamide gradient gel electrophoresis

American Journal of Clinical Pathology

Volumn 119, Issue 3, 2003, Pages 439-445

  Hirany, Shaina V ^a   Othman, Yusra ^a   Kutscher, Patricia ^a   Rainwater, David L ^b   Jialal, Ishwarlal ^c,d   Devaraj, Sridevi ^c  

^a PARKLAND HEALTH AND HOSPITAL SYSTEM   (United States)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Laboratory for Atherosclerosis and Metabolic Research   (United States)

Author keywords

LDL size; LDL subfractions; Low density lipoprotein; Risk factor; Small, dense LDL

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACCURACY; ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLASSIFICATION; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; FRACTIONATION; HUMAN; LABORATORY TEST; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MOLECULAR SIZE; OUTCOMES RESEARCH; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYACRYLAMIDE GRADIENT GEL ELECTROPHORESIS; POLYACRYLAMIDE TUBE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN ISOLATION; SEPARATION TECHNIQUE; STANDARD; TRIACYLGLYCEROL BLOOD LEVEL; COMPARATIVE STUDY; METHODOLOGY; MIDDLE AGED; MOLECULAR WEIGHT; REPRODUCIBILITY;

ADULT; AGED; AGED, 80 AND OVER; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR WEIGHT; REPRODUCIBILITY OF RESULTS; TRIGLYCERIDES;

EID: 0037362946     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/H4E6KTYUFFF23HFN     Document Type: Article

References (28)

1. Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA. 1986;256:2823-2828.
2. Coresh J, Kwiterovich PO, Smith HH, et al. Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res. 1993;34:1687-1697.
3. Executive summary of the Third Report of the National Cholesterol Education Program (NECP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
4. Austin MA, King MC, Vranizan KM, et al. Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation. 1990;82:495-506.
5. Austin MA, Hokanson JE, Brunzell JD. Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance. Curr Opin Lipidol. 1994;5:395-403.
6. Campos H, Genest JJ, Blijlevens E, et al. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb. 1992;12:187-195.
7. Griffin BA, Freeman DJ, Tait GW, et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis. 1994;106:241-253.
8. Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA. 1996;276:875-881.
9. Lamarche B, Tchernof A, Moorjani S, et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study. Circulation. 1997;95:69-75.
10. Miller BD, Alderman EL, Haskell WL, et al. Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the Stanford Coronary Risk Intervention Project. Circulation. 1996;94:2146-2153.
11. Musliner TA, Krauss RM. Lipoprotein subspecies and risk of coronary disease. Clin Chem. 1988;34:B78-B83.
12. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res. 1982;23:97-104.
13. Kulkarni KR, Garber DW, Jones MK, et al. Identification and cholesterol quantification of low density lipoprotein subclasses in young adults by VAP-II methodology. J Lipid Res. 1995;36:2291-2302.
14. Swinkels DW, Hak-Lemmers HL, Demacker PN. Single spin density gradient ultracentrifugation method for the detection and isolation of light and heavy low density lipoprotein subfractions. J Lipid Res. 1987;28:1233-1239.
15. Otvos JD, Jeyarajah EJ, Bennett DW, et al. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin Chem. 1992;38:1632-1638.
16. Okazai M, Usui S, Hosaki S. Analysis of plasma lipoproteins by gel permeation chromatography. In: Rifai N, Warnick GR, Dominiczak MH, eds. Handbook of Lipoprotein Testing. 2nd ed. Washington, DC: AACC Press; 1999:647-669.
17. Rainwater DL. Lipoprotein correlates of LDL particle size. Atherosclerosis. 2000;148:151-158.
18. Rainwater DL, Moore PH Jr, Shelledy WR, et al. Characterization of a composite gradient gel for the electrophoretic separation of lipoproteins. J Lipid Res. 1997;38:1261-1266.
19. Stampfer MJ, Krauss RM, Ma J, et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA. 1996;276:882-888.
20. Hoefner DM, Hodel SD, O'Brien JF, et al. Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System. Clin Chem. 2001;47:266-274.
21. Superko HR. Did Grandma give you heart disease? the new battle against coronary artery disease. Am J Cardiol. 1998;82:34Q-46Q.
22. Grundy SM. Small LDL atherogenic dystipidemia, and the metabolic syndrome. Circulation. 1997;95:1-4.
23. Gray RS, Robbins DC, Wang W, et al. Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians: the Strong Heart Study. Arterioscler Thromb Vazc Biol. 1997;17:2713-2720.
24. Shaikh M, Miller NE. Evaluation of a commercial reagent for precipitating human serum low-density lipoprotein. Clin Chim Acta. 1985;152:213-217.
25. Schmitz G, Bottcher A, Barlage S, et al. New approaches to the use of lipoprotein electrophoresis in the clinical laboratory. In: Rifai N, Wamick GR, Dominiczak MH, eds. Handbook of Lipoprotein Testing. 2nd ed. Washington, DC: AACC Press; 1999:593-607.
26. Rajman I, Kendall MJ, Cramb R, et al. Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceridaemic men. Atherosclerosis. 1996;125:231-242.
27. Zambon A, Brown BG, Hokanson JE, et al. Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density. Circulation. 1999;99:1959-1964.
28. Lamarche B. Should we be measuring LDL particle size for a more adequate assessment of coronary heart disease risk? Fats of Life. 2001;15:5-15.